Clinical trial
Study to Evaluate Symptoms in Patients Treated With Nebivolol or Metoprolol Extended-release (ER) for Hypertension
NCT00547300
Study timeline
Study start (actual)2007-10-31Date precision: day
Registry last updated2019-05-21
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Hypertensionunresolved
Interventions
Metoprolol ERDRUG
NebivololDRUG · verified · RxNorm: nebivolol
Sponsors & collaborators
Forest Laboratorieslead sponsor
Mylan Laboratoriescollaborator
Mapped research locations
AtlantaGeorgia, United States1San AntonioTexas, United States1NashvilleTennessee, United States1BirminghamAlabama, United States1Las VegasNevada, United States1CharlestonSouth Carolina, United States1GreenvilleSouth Carolina, United States1HollywoodFlorida, United States1Walnut CreekCalifornia, United States1Beverly HillsCalifornia, United States1WilmingtonNorth Carolina, United States1Pembroke PinesFlorida, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00547300 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.